Mnemo Therapeutics
George Lourenço is an experienced professional who has held various strategic and operational roles in the healthcare and biotech industry. Currently serving as the Vice President at Mnemo Therapeutics, George has a strong background in business development, licensing, and partnership management. With a PhD in Neuroscience and extensive experience in academic research, George brings a unique blend of scientific expertise and business acumen to their roles.
This person is not in any teams
Mnemo Therapeutics
1 followers
Mnemo Therapeutics is a biotechnology company focused on developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. Its EnfiniT platform, a groundbreaking drug discovery engine, leverages a new class of antigens with greater tumor specificity and a suite of technologies to significantly improve T cell memory, persistence, and sensitivity. The result is dramatic improvement in the body’s immune response to overcome disease. Mnemo is built by a transatlantic team of scientists and biotech leaders united in their mission to create the most powerful immune therapies to deliver accessible cures for all patients in need.